In the urothelial carcinoma [47], prostate adenocarcinoma [48] and breast carcinoma [49] HYAL1 has been considered the mostly expressed tumor-derived hyaluronidase. This evidence concerns the gene HYAL1 and prostate adenocarcinoma.